Max-Planck Institute of Experimental Medicine

Participant's Lead

Participant's Co-Lead

Project Staff

Partner Presentation

Research in the Max Planck Institute of Experimental Medicine focuses on basic and clinical neuroscience 'from molecules to diseases'. It houses three basic neuroscience departments, one clinical neuroscience division, and nine independent research groups. Key core facilities include a proteomics, an EM, and a confocal and live cell imaging facility, a large mouse behaviour facility, and an outpatient clinic. Given the breadth of methodological approaches represented, the institute is an autarkic and powerful neuroscience research unit, embedded into one of the largest and most prolific local neuroscience communities in Europe. Highly cited work in top journals ranges from molecular studies on synapse formation and function, myelin and glia function, and ion channel function, via cell biological and electrophysiological studies on neuron and glia function, to the analysis of mouse models of psychiatric disorders and clinical studies in neurology and psychiatry. Work in the Department of Molecular Neurobiology (head Nils Brose) focuses on molecular mechanisms of synapse formation and function, and on the role of these processes in psychiatric and neurological diseases. The methods spectrum includes biochemistry, molecular biology, mouse genetics, light-microscopic imaging, EM, and electrophysiology. Nils Brose is coordinator of the EUROSPIN consortium (HEALTH-F2-2009-241498). The Division of Clinical Neuroscience (head Hannelore Ehrenreich) focuses on translational neuroscience including mouse behavior and clinical studies, from human genetics to treatment trials.